Hajir Dakheel | Medicine | Best Scholar Award

Published on by Research Hypothesis

Best Scholar Award

Hajir Dakheel
University of Tripoli, Libya
Hajir Dakheel
Affiliation University of Tripoli
Country Libya
Documents 6
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0009-0004-1696-7977

Hajir DakheelΒ  the Best Scholar Award recognizes researchers who have demonstrated meaningful scholarly engagement, research productivity, and contributions to their academic discipline. Hajir Dakheel of the University of Tripoli has established a documented research presence in the field of medicine through scholarly publications and participation in scientific inquiry. The award evaluation considers academic output, research relevance, publication quality, and alignment with the objectives of the International Research Hypothesis Excellence Award.[1]

Abstract

This article presents an academic overview of Hajir Dakheel in consideration for the Best Scholar Award under the International Research Hypothesis Excellence Award program. The assessment is based on documented scholarly activities, publication records, institutional affiliation, and demonstrated engagement within the field of medicine. Through a portfolio comprising multiple indexed publications, the researcher has contributed to scientific discourse and knowledge dissemination. The evaluation highlights research consistency, academic participation, and potential influence on future medical investigations.[1][2]

Keywords

Best Scholar Award; Medicine; Medical Research; Scholarly Publications; Academic Excellence; University of Tripoli; Research Evaluation; Scientific Contributions; Research Impact; International Research Hypothesis Excellence Award.

Introduction

Recognition through academic awards serves an important role in highlighting contributions that advance scientific understanding and professional scholarship. The Best Scholar Award acknowledges researchers whose work demonstrates academic rigor, publication activity, and relevance to contemporary scientific challenges. Within the medical sciences, scholarly efforts contribute to the improvement of healthcare knowledge, evidence-based practice, and future research development.[2]

Hajir Dakheel’s academic profile reflects participation in medical research and scholarly communication. The available publication record provides evidence of engagement with research activities that support knowledge generation and dissemination within the broader medical community.[1]

Research Profile

Hajir Dakheel, a researcher at the University of Tripoli, has demonstrated notable contributions to the field of Medicine through six indexed publications. With an ORCID identifier of 0009-0004-1696-7977, Dr. Dakheel’s scholarly work reflects dedication to advancing medical research and academic excellence.

The research profile indicates active participation in scientific publication and academic dissemination. Such activities contribute to institutional research visibility and support the advancement of evidence-based medical knowledge.[1]

Research Contributions

The documented body of work reflects engagement with medical research topics relevant to healthcare advancement and scientific inquiry. Contributions include participation in scholarly publications, dissemination of research findings, and support for evidence generation within the medical sciences. Research outputs contribute to the academic literature by addressing contemporary healthcare questions and promoting scientific discussion.[2]

Publications

Available records indicate six indexed scholarly documents associated with the researcher. These publications collectively demonstrate research activity and participation in academic dissemination. Publication output is a significant criterion in scholarly evaluation because it reflects the communication of findings to the scientific community.[1]

Representative DOI-linked scholarly literature relevant to medical research standards includes examples such as illustrating the importance of persistent scholarly identifiers in research communication.[3][4]

Research Impact

Research impact may be assessed through publication activity, scholarly visibility, academic collaboration, and contribution to scientific knowledge. The documented publication portfolio indicates ongoing participation in the research ecosystem and supports the dissemination of medical knowledge. Such activities strengthen institutional academic standing and encourage future scientific investigations.[1][2]

Award Suitability

Based on the available academic profile, Hajir Dakheel demonstrates characteristics commonly associated with eligibility for scholarly recognition programs. Relevant factors include documented research productivity, institutional affiliation with a recognized academic institution, engagement in medical research, and participation in scientific publication activities. These indicators align with the evaluation principles frequently applied in research excellence and scholar recognition awards.[1][5]

Conclusion

Hajir Dakheel’s academic profile reflects meaningful participation in medical research and scholarly publication. Through documented research outputs and engagement with scientific communication, the researcher contributes to the advancement of medical knowledge. The available evidence supports consideration for the Best Scholar Award within the framework of the International Research Hypothesis Excellence Award, recognizing scholarly commitment, research dissemination, and academic achievement.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Hajir Dakheel. Scopus.
  2. University of Tripoli. (n.d.). Institutional academic and research information.
  3. The Lancet. (2020). Novel Coronavirus Research. DOI: 10.1016/S0140-6736(20)30183-5.
    https://doi.org/10.1016/S0140-6736(20)30183-5
  4. New England Journal of Medicine. (2020). Clinical Medical Research Example. DOI: 10.1056/NEJMoa2001017.
    https://doi.org/10.1056/NEJMoa2001017
  5. International Research Hypothesis Excellence Award. (n.d.). Award evaluation framework and recognition criteria.
    https://researchhypothesis.com/

Tong Qiao | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Dr. Tong Qiao | Medicine and Health Sciences | Research Excellence Award

Dr. Tong Qiao | Medicine and Health Sciences | Head of ophthalmology at Shanghai Jiao Tong University | ChinaΒ 

Dr. Tong Qiao is a distinguished clinician-scientist in pediatric ophthalmology with extensive expertise in the diagnosis and management of complex childhood eye disorders. She completed her foundational medical training with a Bachelor of Medicine, followed by a Master of Medicine, and later earned a Doctor of Philosophy in medicine from leading academic institutions in China, establishing a strong academic and clinical foundation in ophthalmology. Dr. Tong Qiao has authored 35 scholarly documents, received 343 citations, and maintains a 9 h-index, reflecting consistent academic influence and international research visibility in indexed scientific literature. Her publication record includes contributions to reputable, peer-reviewed journals, supporting evidence-based advancements in pediatric ophthalmology and visual sciences.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
343

Documents
35

h-index
9

🟦 CitationsΒ  Β  Β  Β πŸŸ₯ DocumentsΒ  Β   🟩 h-index


View Scopus Profile

Featured Publications

Digital measurement of pupil size, corneal size, and eccentricity in Guinea pigs using Python compared with traditional OCT
– Scientific Reports, Open Access
Bilateral superior oblique suture extension in pediatric A-pattern esotropia
– Medical Hypothesis Discovery and Innovation in Ophthalmology, Open Access
Surgical treatment and levator muscle protein analysis of congenital ptosis in craniosynostosis: A case-control study
– Medicine, Open Access

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Research Scholar, Gurukul Kangri, Deemed to be University, Haridwar, India

Mrs. Shalini Singh 🌸 is a highly accomplished scientific writer and researcher specializing in phytopharmacology 🌿, herbal medicine 🌼, and integrative therapeutics πŸ§ͺ. With a Master’s in Pharmacology πŸŽ“ and currently pursuing her Ph.D. 🎯 at Gurukula Kangri University, Haridwar, she has made outstanding contributions to academic and regulatory scientific writing πŸ“š. She worked at Patanjali Research Foundation 🌱 from 2018-2022, authoring numerous high-impact peer-reviewed articles, monographs, and dossiers. Mrs. Singh has collaborated with multidisciplinary teams πŸ‘©β€πŸ”¬, contributed to national and international initiatives like NMCG and AYUSH 🌍, and reviewed for top journals like Elsevier and Springer πŸ“. Her work bridges traditional wisdom and modern science, embodying excellence 🌟, dedication πŸ’ͺ, and innovation πŸ’‘. She continues to inspire through her research, scientific integrity, and pursuit of holistic healthcare solutions 🌏.

Publication Profile

Orcid

Experience

Mrs. Singh is a skilled Scientific Writer πŸ–‹οΈ who worked at Patanjali Research Foundation, Haridwar (May 2018–Nov 2022), where she authored peer-reviewed articles πŸ“„, pharmacological monographs πŸ“‘, systematic reviews πŸ“š, and regulatory documents πŸ›οΈ. She specialized in herbal medicine 🌿, clinical data analysis πŸ“Š, and scientific dossier preparation, demonstrating a strong command over both scientific detail and regulatory standards. Earlier, she served as an Assistant Professor πŸŽ“ at Lords International College of Pharmacy, Alwar (Dec 2017–April 2018), engaging in teaching πŸ“š, mentoring students 🎯, curriculum development ✍️, and academic research πŸ§ͺ. Throughout her career, Mrs. Singh collaborated with interdisciplinary teams 🀝, reviewed manuscripts for leading journals πŸ“°, and contributed to national projects initiated by the Ministry of AYUSH and the NMCG 🌐. Her work consistently reflects a unique blend of scientific rigor πŸ”¬, exceptional communication skills πŸ—£οΈ, and regulatory precision πŸ“, establishing her as an invaluable asset to the research community.

Awards and Honors

Mrs. Shalini Singh exemplifies academic excellence πŸ“š, leadership πŸ…, and a deep commitment to advancing healthcare research and Ayurvedic sciences 🌿. As a dedicated peer reviewer πŸ–ŠοΈ for prestigious journals like Elsevier, Springer, Wiley, Bentham Science, and Frontiers 🌍, she actively contributes to the scientific community. She has participated 🎀 in multiple national and international conferences 🌏, including “Modernization of Traditional Indian Medicine” 🌱, “Emerging Scenario of Science, Technology & Innovation-2023” πŸ”¬, and “Plants to Patients – Series 3: Rethinking Ethnopharmacology” 🌸. Her scholarly engagements extend further with her successful completion πŸ† of the DST-Sponsored STUTI Training Program at SATHI-BHU, Varanasi πŸŽ“. Mrs. Singh’s numerous participations, invited talks, and reviewer roles highlight her dynamic presence in the academic world, showcasing her drive to foster innovation and interdisciplinary collaboration. Her work continues to impact the fields of ethnopharmacology and traditional medicine, inspiring future researchers and practitioners alike 🌟.

Research Focus

Mrs. Shalini Singh’s research centers around phytopharmacology 🌱, herbal medicine 🌿, ethnopharmacology 🧬, and integrative therapeutics πŸ’Š. She has explored the anti-diabetic 🌟, anti-inflammatory πŸ§ͺ, and wound healing 🩹 potentials of natural products and traditional herbs. Her interest extends to modernizing Ayurvedic treatments πŸ§˜β€β™€οΈ through evidence-based studies, clinical evaluation πŸ“Š, and data synthesis from ethnobotanical sources πŸ“š. She has worked on national and global projects 🌏, authoring scientific dossiers, monographs, and manuscripts that bridge the gap between traditional medicine and contemporary healthcare practices 🧠. In addition to primary research, she emphasizes scientific communication πŸ–‹οΈ, regulatory documentation πŸ“‘, and the development of novel therapeutics πŸš€, making her a key player in promoting holistic, sustainable healthcare innovation 🌼.

Publication Top Notes

Research Articles:

  • πŸ“„ Evaluation of Anti-Diabetic activity of fruits of Withania coagulans in streptozotocin-induced diabetic rats.

  • πŸ“„ Anti-Hyperglycemic activity of Pithecellobium dules plant extracts on blood glucose levels of streptozotocin-induced diabetic rats.

  • πŸ“„ Effectiveness of Ayurvedic Regimens in Managing Polycystic Ovarian Syndrome and Related Comorbidities: An Observational Study.

  • πŸ“„ Exploring the Role of Herbo-mineral Combinations for the Management of Hypothyroidism.

  • πŸ“„ Elevating the Inner-Consciousness β€œThird Eye” Through β€œVedic Manas Yoga” Practice.

  • πŸ“„ Effect of various extracts from Ficus retusa L. stem bark on wound healing potential.

Review Articles:

  • πŸ“š Ayurvedic Approaches to Managing Premature Greying of Hair: A Comprehensive Review.

  • πŸ“š Small molecule inhibitors target multiple neuropathological signaling to exert novel neuroprotection in intracranial aneurysms.

  • πŸ“š Nature’s Signature in Ayurveda with an Ethnopharmacological Approach: A Narrative Review.

  • πŸ“š Nanotechnology in the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Scoping Analysis.

  • πŸ“š Impact of Biosensors and Biomarkers in Diabetes Care: A Review.

  • πŸ“š Swertia chirayita (Roxb.) H. Karst.: A Magnificent Natural Remedy for Gastrointestinal Disorders.

  • πŸ“š Effect of Coliform Bacteria on Various Environmental Factors: A Review.

  • πŸ“š Hazardous Consequences and Management of Heavy Metals in Sewage Sludge: An Overview.

  • πŸ“š Withania coagulans Dunal.: A Narrative Review of an Anti-diabetic Shrub of the Desert Biome.

  • πŸ“š Bartogenic Acid: A Promising Pentacyclic Triterpenoid in Cancer Research and Possible Mechanism.

 

Gulali Aktas | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Gulali Aktas | Medicine and Health Sciences | Best Researcher Award

Prof Dr Gulali Aktas, Abant Izzet Baysal University Hospital, Turkey

Prof. Dr. Gulali Aktas is a dedicated physician with 24 years of experience in internal medicine. As an academician for 13 years, he has mentored countless medical students and contributed to significant research. He holds an MD and Associate Professorship from Abant Izzet Baysal University. His prolific work includes 183 international journal publications, 19 conference presentations, and 11 book chapters. Recognized for his excellence, he was nominated for the Raise the Line Faculty Award in 2022 and is listed in Stanford University’s top 2% scientists. Fluent in Turkish, English, and basic German, he champions patient-centered care and lifelong learning. πŸ₯πŸ“šπŸŒŸ

Publication profile

google scholar

Education

Dr. Gulali Aktas is an Associate Professor of Internal Medicine since 2015. They completed their Internal Medicine residency (PhD equivalent) at Ondokuz Mayis University, Samsun, Turkey (2003-2008), and Pulmonology residency at Yedikule Training and Research Hospital, Istanbul, Turkey (2002-2003). They earned their MD from Ondokuz Mayis University in 2000. With 211 research contributions published in peer-reviewed journals and an impressive H-index of 35 (WoS), 42 (Google Scholar), and 36 (Scopus), Dr. Gulali Aktas is a prominent researcher. Fluent in Turkish, English, and basic German, they are known for their honesty, hard work, optimism, and foresight. πŸŒŸπŸ“šπŸ©ΊπŸŒ

Experience

From 2011 to 2014, courses such as Dyspnea and Edema, Approach to Chest Pain, Fever and Hyperthermia, and Leukopenia and Leukocytosis were taught in the spring, while Chronic Leukemia, Aplastic Anemia and Myelodysplasia, and Principles of Blood Transfusion were covered in the autumn. Rheumatology topics like Anamnesis, Physical Examination, and Laboratory Test Analysis were emphasized. Other subjects included Familial Mediterranean Fever, Behcet’s Disease, Chronic Pancreatitis, Liver Cirrhosis, Esophageal Diseases, Colon Polyps, Celiac Disease, Chronic Viral and Non-Viral Hepatitis, and Mesenteric Ischemia. πŸ©ΊπŸ“šβœ¨

Presentations

Dr. Gulali Aktaş has presented several notable studies. At the 30th World Congress of Endourology in 2012, his team discussed “Warfarin intoxication induced bilateral renal hematoma” (πŸ“šπŸ©Έ). He compared surgical techniques for pylonidal sinus surgery and explored sleep quality in IBS patients at the XVI Annual European Society of Surgery (πŸ”ͺπŸ’€). In 2013, at the 50th ERA-EDTA Congress, he highlighted the effects of nocturnal blood pressure on hemodialysis patients’ nutrition (πŸŒ™πŸ©Ί). His research on metabolic syndrome, presented at the 10th Metabolic Syndrome Symposium, investigated platelet volume, epicardial adipose tissue, and non-alcoholic hepatosteatosis (πŸ©ΈπŸ“ˆ). At the 51st ERA-EDTA Congress, he examined atrial conduction in hemodialysis patients (❀️🩺).

Research focus

G Aktas focuses on the use of hematological and biochemical markers as diagnostic and prognostic tools in various medical conditions. His research includes studies on the neutrophil-to-lymphocyte ratio as an indicator for diabetic control in type 2 diabetes mellitus and Hashimoto’s thyroiditis. He also explores the predictive value of the uric acid to HDL cholesterol ratio for metabolic syndrome and diabetes control, as well as novel inflammatory markers derived from hemogram parameters in irritable bowel syndrome and COVID-19. His work aims to improve diagnostic accuracy and patient outcomes. πŸ©ΈπŸ”¬πŸ“Š

Publication top notes

Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus

Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis

Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus

Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?

Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus

Diabetes control could through platelet-to-lymphocyte ratio in hemograms

Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters

Could red cell distribution width be a marker in Hashimoto’s thyroiditis?

Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men

Hematological predictors of novel Coronavirus infection